MTOR and urinary bladder carcinoma: Angiogenin, belonging to the ribonuclease A family, has been reported to enhance angiogenesis and metastatic progression in bladder cancer through the activation of critical downstream elements within the PI3K–AKT–mTOR pathway (40).